Prime Medicine, Inc.PRMENASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+22.8%
5Y CAGR+122.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+22.8%/yr
Annual compound
5Y CAGR
+122.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
53.9x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $160.64M | +3.4% |
| 2024 | $155.29M | +5.0% |
| 2023 | $147.91M | +70.5% |
| 2022 | $86.72M | +22.9% |
| 2021 | $70.55M | +2267.4% |
| 2020 | $2.98M | +223.9% |
| 2019 | $920000.00 | - |